Description
Sc. cerevisiae sp. boulardii helps prevent pathogens from entering the bloodstream and creates a favorable environment for microorganisms (e.g., lactic acid bacteria). BIOLATTE boulardii has shown good results in Finland for over 15 years. The patented manufacturing process gives the product three-year stability at room temperature. The product is safe even for long-term use. It is also suitable for use during illness periods, including for infants to alleviate digestive and gas problems.
This is not nutritional yeast. It does not cause the growth of pathogenic yeast. Also suitable for those suffering from yeast allergies, as it is not the usual (nutritional) yeast. Free from casein, lactose, yeast, and gluten.
S. boulardii has been used as a probiotic in Europe since the 1950s, and numerous clinical studies have been conducted with S.boulardii worldwide. Safety information gathered during these studies has established S. boulardii a significant safety profile. Analysis of safety data from 2963 patients revealed that the only side effects associated with S. boulardii were thirst (in 5 patients) and constipation (in 8 patients).
In numerous S. boulardii efficacy studies, it has been highlighted that the consumption of S.boulardii did not cause side effects, even when consumed for six consecutive months. S. boulardii has also been given to AIDS patients without any serious side effects.
Clinical efficacy of S. boulardii
- Antibiotic-associated diarrhea (AAD): The efficacy of S. boulardii in preventing AAD has been proven in numerous studies.
- Clostridium difficile infection (CDI): Combining S. boulardii with standard treatment significantly reduces the recurrence of CDI.
- Acute and persistent diarrhea: S. boulardii is highly effective in treating diarrhea of various causes in adults and significantly reduces the duration of acute diarrhea in children. S. boulardii has also proven effective in persistent diarrhea in children.
- Helicobacter pylori infection: S. boulardii improves the tolerance of standard triple therapy against H. pylori, reducing side effects like diarrhea, upper abdominal discomfort, and post-treatment dyspepsia.
- Crohn’s disease: In addition to alleviating diarrhea, S. boulardii also has positive effects on clinical parameters such as lower abdominal pain, general well-being, hematocrit levels, etc. Adding S. boulardii to standard treatment significantly reduces relapse in Crohn’s disease (6.25% vs 37.5%).
- Irritable bowel syndrome (IBS): Taking S. boulardii may improve IBS treatment outcomes and the quality of life for IBS patients.
- Parasitic infections like Giardia lamblia: Besides treating diarrhea, S.boulardii also helps eliminate Giardia cysts.
- HIV-associated diarrhea: In a study conducted in France on Stage 4 AIDS patients, diarrhea was resolved in 61% of patients taking S. boulardii, compared to only 12% of those receiving placebo. S. boulardii was well tolerated by all patients, even at high doses (3g per day).
Reviews
There are no reviews yet.